Department of Gynecology, Jeanne de Flandre University Hospital, 59000 Lille, France.
Department of Obstetrics and Gynecology, McGill University, Montréal, QC, Canada.
Eur J Obstet Gynecol Reprod Biol. 2023 Dec;291:162-167. doi: 10.1016/j.ejogrb.2023.10.027. Epub 2023 Oct 21.
The aim of the present study was to compare efficacy and safety of the vaginal patch plastron (VPP) associated to the anterior sacrospinous fixation (SSLF-A) with a TVM procedure (Uphold™ LITE support-system) for the treatment of the advanced anterior vaginal wall prolapse.
Single-center retrospective study. Women with symptomatic anterior prolapse ≥ III stage according to the POP-quantification (POP-Q) system and submitted to the VPP associated with the SSLF-A or to the Uphold™ procedure were included. Primary outcome was to compare objective and subjective cystocele relapse and reoperation rate at 6- and 12-month follow-up. Secondary outcome was to describe peri- and postoperative complications. Pearson chi-square test and exact Fisher test were adopted for categorical variables, while intergroup Mann-Whitney U test and intragroup Wilcoxon Rank Sum Test for continuous variables; the statistical analysis was conducted at 95 % confidence level.
Fifty-five women in VPP-group and 118 women in Uphold-group were included. At 6-month follow-up, objective anterior relapse in VPP-group (3/55, 5.4 %) was like Uphold-group (5/118, 4.2 %; p = 0.71), as well as objective apical relapse (0/55, 0 % vs 3/118, 2.5 %; p = 0.55); no significant difference emerged in bulge symptoms (1/55, 1.8 % vs 5/118, 4.2 %; p = 0.67). At 12-month follow-up women were telephonically investigated; no significant difference emerged in bulge symptoms (1/55, 1.8 % vs 6/118, 5.1 %; p = 0.43). Reoperation rate for the composite outcome POP relapse, stress urinary incontinence (SUI) and remotion of the TVM resulted lower in the VPP group (1/55, 1.8 % vs 13/118, 11 %; p = 0.03). Post-operative buttock pain (32/55, 58.2 % vs 24/118, 20.3 %; p < 0.0001) and post-operative urinary retention (16/55, 29.1 % vs 6/118, 5.1 %; p < 0.0001) were higher in VPP-group, with a complete resolution between 2 and 3 weeks after treatment.
VPP associated with SSLF-A was as effective as Uphold™ LITE support-system for both anterior and central compartment prolapse treatment at 6- and 12-month follow-up. VPP-group presented a lower reoperation rate for the composite outcome prolapse relapse repair, SUI, and removal of the mesh.
本研究旨在比较阴道补丁胸甲(VPP)联合前骶骨固定(SSLF-A)与 TVM 手术(Uphold™ LITE 支撑系统)治疗晚期前阴道壁脱垂的疗效和安全性。
单中心回顾性研究。纳入符合 POP 定量(POP-Q)系统诊断为≥III 期前阴道脱垂症状的女性,并接受 VPP 联合 SSLF-A 或 Uphold™ 手术治疗。主要结局是比较 6 个月和 12 个月随访时的客观和主观膀胱膨出复发和再次手术率。次要结局是描述围手术期并发症。采用卡方检验和精确 Fisher 检验进行分类变量分析,采用组间 Mann-Whitney U 检验和组内 Wilcoxon 秩和检验进行连续变量分析;统计分析置信水平为 95%。
VPP 组 55 例,Uphold 组 118 例。6 个月随访时,VPP 组(3/55,5.4%)的前侧复发率与 Uphold 组(5/118,4.2%;p=0.71)相似,前顶复发率(0/55,0%vs 3/118,2.5%;p=0.55);膨出症状无显著差异(1/55,1.8%vs 5/118,4.2%;p=0.67)。12 个月随访时,对患者进行电话调查;膨出症状无显著差异(1/55,1.8%vs 6/118,5.1%;p=0.43)。VPP 组复合结局 POP 复发、压力性尿失禁(SUI)和 TVM 移除的再次手术率较低(1/55,1.8%vs 13/118,11%;p=0.03)。VPP 组术后臀部疼痛(32/55,58.2%vs 24/118,20.3%;p<0.0001)和术后尿潴留(16/55,29.1%vs 6/118,5.1%;p<0.0001)发生率较高,但在治疗后 2-3 周内完全缓解。
VPP 联合 SSLF-A 治疗前阴道和中央隔膨出的疗效与 Uphold™ LITE 支撑系统在 6 个月和 12 个月随访时相似。VPP 组复合结局(POP 复发修复、SUI 和网片移除)的再次手术率较低。